Rene Aleman, MD, Joel S Frieder, MD, Carlos Rivera, MD, Federico Serrot, MD, Emanuele Lo Menzo, MD, PhD, FACS, FASMBS, Raul Rosenthal, MD, FACS, FASMBS. Cleveland Clinic Florida
Neuroendocrine tumors of the stomach are a less common type of gastric neoplasms reported in 8.7% of gastric. We present the case of a 69-year-old male with a 5-month history of a high-grade neuroendocrine tumor of the gastric body. Initially, the patient complained of chronic bloating and anemia-associated symptoms which led to an initial endoscopy. The patient received 4 rounds of neo-adjuvant chemotherapy, but the chemotherapy was suspended due to thrombocytopenia. The patient was scheduled for total laparoscopic gastrectomy (TLG). The patient made an uneventful recovery and the final pathology was consistent with a gastric neuroendocrine tumor (GNT) type 1.
Presented at the SAGES 2017 Annual Meeting in Houston, TX.
Abstract ID: 95469
Program Number: V329
Presentation Session: Video Loop Day 3
Presentation Type: VideoLoop
sages_adbutler_leaderboard